2010
• Bilardi, J. et al. Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial. BMC Infectious Diseases 10 (2010)
• Boddey, J. A. et al. An aspartyl protease directs malaria effector proteins to the host cell. Nature 463, 627-631, (2010).
• Boyle, M. J., Richards, J. S, Gilson, P. R., Chai, W. & Beeson, J. G. Interactions with heparin-like molecules during erythrocyte invasion by P. falciparum merozoites. Blood (2010).
• Burgess, M. et al. Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Vaccine (2010).
• Crabb, B. S., de Koning-Ward, T. F. & Gilson, P. R. Protein export in Plasmodium parasites: From the endoplasmic reticulum to the vacuolar export machine. Int. J. Parasitol. (2010).
• Dore, G. J. et al. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 138, 123-135 (2010).
• Flynn J , Dore G , Hellard M , Yeung B , Rawlinson W , White P , Kaldor J , Lloyd A , Ffrench R on behalf of the ATAHC Study Group. Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J Viral Hepatitis. (2010)
• Grebely J, Petoumenos K, Matthews G, Haber P, Marks P, Lloyd A, Kaldor J, Dore G, Hellard M and for the ATAHC Study Group. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study Drug and Alcohol Dependence Volume 107, Issues 2-3, , 244-249 (2010)
• Horyniak, D. et al. An evaluation of a heroin overdose prevention and education campaign. Drug Alcohol Rev 29, 5-11, (2010).
• Hutton, J. et al. The characteristics of acute non-fatal medication-related events attended by ambulance services in the Melbourne Metropolitan Area 1998-2002. Drug Alcohol Rev 29, 53-58, (2010).
• Kirwan, A ‘Does opioid substitution treatment in prisons reduce injecting related HIV risk behavi. ours? A systematic review’ (article review) ASHM Journal Club, Vol. 19, Issue 1, pp 1-2. (2010)
• Ryan, J., Voon, D., Kirwan, A., Levy, M., Sutton, L. ‘Prisons, Needles and Occupational Health and Safety’ . Journal of Health Safety and Environment 26(1), pp 63-72. (2010)
• Marfurt, J. et al. Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance. Malaria journal 9, 8 (2010).
• Reid, G. & Higgs, P. Vietnam moves forward with harm reduction: An assessment of progress. Glob Public Health, 1-13, (2010).
• Senn N, Riddell M, Omena M, Siba P, Reeder J, Clements J, Morgan C Measles in Papua New Guinea: an age-specific serological survey. Vaccine 28, 1819-1823, (2010).

2009

    • Aitken C, Lewis J, Hocking J, Bowden S & Hellard M. Does information about IDUs’ injecting networks predict exposure to the hepatitis C virus? . Hepatitis Monthly 9, 17-23 (2009).
    • Aitken, C., Dwyer R & Power R. Is handedness associated with health status for people who inject illicit drugs? . Drugs: Education, Prevention and Policy (2009).
    • Aitken, C., Fry, T., Farrell, L. & Pellegrini, B. Smokers of illicit tobacco report significantly worse health than other smokers. Nicotine and Tobacco Research (2009).
    • Allsop, S., Loxley, W. & Rechichi, V. Twenty years' research from the National Drug Research Institute. Drug Alcohol Rev 28, 95, (2009).
    • Barry, A. E., Schultz, L., Buckee, C. O. & Reeder, J. C. Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PloS one 4, e8497 (2009).
    • Bharadwaj, M. et al. TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus. Immunol. Cell Biol. 87, 464-472, (2009).
    • Bharadwaj, M. et al. TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus. Immunol. Cell Biol. 87, 464-472 (2009).•
    • Boyle, M., Richards, J. S., Gilson, P. R., Chai, W. G. & Beeson, J. G. Cellular and molecular interactions with heparin-like molecules during invasion of erythrocytes by plasmodium falciparum merozoites. Am. J. Trop. Med. Hyg. 81, 318 (2009).
    • Bullen, H. E. et al. A novel family of Apicomplexan glideosome-associated proteins with an inner membrane-anchoring role. J. Biol. Chem. 284, 25353-25363 (2009).
    • Buykx, P., Dietze, P., Ritter, A. & Loxley, W. Characteristics of medication overdose presentations to the ED: how do they differ from illicit drug overdose and self-harm cases? Emerg Med Australas (2009).
    • Chan, K. Y., Yang, Y., Li, Z. R., Stoove, M. A. & Reidpath, D. D. Interrelationships between HIV/AIDS and risk behavior prejudice among medical students in Southern China. Current HIV research 7, 601-611 (2009).
    • Chikritzhs, T. N. et al. The "alcopops" tax: heading in the right direction. Med. J. Aust. 190, 294-295 (2009).
    • Cox, H. S., Ford, N. & Reeder, J. C. Are we really that good at treating tuberculosis? The Lancet infectious diseases 9, 138-139 (2009).
    • Dale, K., Wolfe, R., Sinclair, M., Hellard, M. & Leder, K. Sporadic gastroenteritis and recreational swimming in a longitudinal community cohort study in Melbourne, Australia. Am. J. Epidemiol. 170, 1469-1477, (2009).
    • Degenhardt, L. et al. The epidemiology of ecstasy use and harms in Australia. Neuropsychobiology 60, 176-187, (2009).
    • de Koning-Ward, T. F. & Gilson, P. R. Keeping it simple: an easy method for manipulating the expression levels of malaria proteins. Trends in parasitology 25, 4-7, (2009).
    • de Koning-Ward, T. F. et al. A newly discovered protein export machine in malaria parasites. Nature 459, 945-949, (2009).
    • Dietze, P. M. et al. Income inequality and alcohol attributable harm in Australia. BMC public health 9, 70 (2009).
    • Dietze, P., Powell, M. & Thomson, D. Mental reinstatement of context with child witnesses: Does it matter whether context is reinstated "out loud"? Psychology Crime & Law (2009).
    • Dwyer, R. et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend. 100, 9-16, (2009).
    • Dwyer, R. et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend. 100, 9-16, (2009).
    • Fielding, J. et al. Pandemic H1N1 influenza surveillance in Victoria, Australia, April - September. Euro Surveill 14, (2009).
    • Franklin, l., Armstrong, S., Hellard , M. & Higgs, P. Research conducted by mixed field teams: What have we learnt? Drug & Alcohol Review 28, A22 (2009).
    • Fry, T., Grahlmann, L., Masters, T., Pellegrini, B. & Aitken, C. Understanding the motivations of contraband tobacco smokers. European Journal of Public Health (2009).
    • Gidding, H. F. et al. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. J. Gastroenterol. Hepatol. 24, 1648-1654 (2009).
    • Giles, M. L. et al. Antenatal screening practice for infectious diseases by general practitioners in Australia. Aust. N. Z. J. Obstet. Gynaecol. 49, 39-44, (2009).
    • Giles, M. L., Hellard, M. E., Lewin, S. R. & O'Brien, M. L. The "work" of women when considering and using interventions to reduce mother-to-child transmission (MTCT) of HIV. AIDS Care 21, 1230-1237, (2009).
    • Gilson, P. R. & Crabb, B. S. Do apicomplexan parasite-encoded proteins act as both ligands and receptors during host cell invasion? F1000 Biol Reports 1, (2009).
    • Gilson, P. R. & Crabb, B. S. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int. J. Parasitol. 39, 91-96 (2009).
    • Gilson, P. R. Malaria parasites do the stick-and-slip shuffle. Cell host & microbe 6, 499-501 (2009).
    • Guy, R. et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. The Lancet infectious diseases 9, 747-759 (2009).
    • Guy, R. et al. No increase in HIV or sexually transmissible infection testing following a social marketing campaign among men who have sex with men. J. Epidemiol. Community Health 63, 391-396, (2009).
    • Guy, R. J., Prybylski, D., Fairley, C. K., Hellard, M. E. & Kaldor, J. M. Can data from HIV voluntary counselling and testing be used to assess the impact of public health interventions? A literature review. Int. J. STD AIDS 20, 378-383, doi:20/6/378 (2009).
    • Heffernan, E., Andersen, K. & Kinner, S. The insidious problem inside: mental health problems of Aboriginal and Torres Strait Islander People in custody. Australas Psychiatry 17 Suppl 1, S41-46, (2009).
    • Hellard, M. E. & Wang, Y. H. The role of general practitioners in managing and treating hepatitis C. Med. J. Aust. 191, 523-524, (2009).
    • Hellard, M., Sacks-Davis, R. & Gold, J. Hepatitis C treatment for injection drug users: a review of the available evidence. Clin. Infect. Dis. 49, 561-573, (2009).
    • Hides, L. et al. The relationship between personality disorders and mental health. substance use severity and quality of life among injecting drug users Drug and Alcohol Review (2009).
    • Higgs, P. et al. Heroin-gel capsule cocktails and groin injecting practices among ethnic Vietnamese in Melbourne, Australia. The International journal on drug policy 20, 340-346, (2009).
    • Higgs, P. et al. Peer education with current injectors in Queensland: a review of the Mix up Project. Drug & Alcohol Review 28, A28 (2009).
    • Higgs, P., Jordens, J., Maher, L. & Dunlop, A. Vietnamese-Australian heroin users' perspectives on teh role of the family in treatment. Drugs: Education, Prevention and Policy 16, 409-421 (2009).
    • Higgs, P., Winter, R., Hellard, M. & Aitken, C. What impacts do social networks have on hepatitis C transmission for people who inject drugs in Melbourne. Good Liver, 10-11 (2009).
    • Higgs, P., Yohannes, K., Hellard, M. & Maher, L. Factors influencing a self-limiting HIV outbreak among ethnic Vietnamese injecting drug users in Melbourne, Australia. Qual. Health Res. 19, 1690-1701, (2009).
    • Horyniak, D. et al. An evaluation of a heroin overdose prevention and education campaign. Drug Alcohol Rev 29, 5-11 (2009).
    • Horyniak, D. et al. The impact of immigration on the burden of HIV infection in Victoria, Australia. Sex Health 6, 123-128, (2009).
    • Jallow, M. et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet (2009).
    • Kerr, D., Dietze, P., Kelly, A. M. & Jolley, D. Improved response by peers after witnessed heroin overdose in Melbourne. Drug Alcohol Rev 28, 327-330 (2009).
    • Kerr, D., Kelly, A. M., Dietze, P., Jolley, D. & Barger, B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction 104, 2067-2074 (2009).
    • Kinner, S. A., George, J., Campbell, G. & Degenhardt, L. Crime, drugs and distress: patterns of drug use and harm among criminally involved injecting drug users in Australia. Aust. N. Z. J. Public Health 33, 223-227 (2009).
    • Kinner, S., Lennox, N. & Taylor, M. Randomised controlled trial of a post-release intervention for prisoners with and without an intellectual disability. Journal on developmental disabilities 15, 72-76 (2009).
    • Kong, F. Y. S., Hocking, J. S., Link, C. K., Chen, M. Y. & Hellard, M. E. Sex and sport: chlamydia screening in rural sporting clubs. BMC Infectious Diseases 9, 73 (2009).
    • Kong, F. Y., Hocking, J. S., Link, C. K., Chen, M. Y. & Hellard, M. E. Sex and sport: chlamydia screening in rural sporting clubs. BMC Infect Dis 9, 73, (2009).
    • Lemoh, C. et al. African Australians living with HIV: a case series from Victoria. Sexual Health (2010).
    • Lemoh, C. et al. Delayed diagnosis of HIV infection in Victoria 1994 to 2006. Sex Health 6, 117-122, (2009).
    • Lenne, M. G. et al. The effects of cannabis and alcohol on simulated driving: Effects of driving experience and task demand. Accid. Anal. Prev. (2009).
    • Lenton, S. R., Dietze, P. M., Degenhardt, L., Darke, S. & Butler, T. G. Naloxone for administration by peers in cases of heroin overdose. Med. J. Aust. 191, 469 (2009).
    • Lenton, S. R., Dietze, P. M., Degenhardt, L., Darke, S. & Butler, T. G. Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia. Drug Alcohol Rev 28, 583-585 (2009).
    • Li, S. et al. Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection Blood (2009).
    • Li, S. et al. Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection. PLoS pathogens 5, (2009).
    • Lim, M. S., Aitken, C. K., Hocking, J. S. & Hellard, M. E. Discrepancies between young people's self-reported sexual experience and their perceptions of 'normality'. Sex Health 6, 171-172, (2009).
    • Lim, M. S., Hellard, M. E., Aitken, C. K. & Hocking, J. S. Surveillance of STI risk behaviour among young people attending a music festival in Australia, 2005-08. Aust. N. Z. J. Public Health 33, 482-484 (2009).
    • Lim, M. S., Sacks-Davis, R., Aitken, C. K., Hocking, J. S. & Hellard, M. E. A randomised controlled trial of paper, online and SMS diaries for collecting sexual behaviour information from young people. J. Epidemiol. Community Health, (2009).
    • Lim, M., Hellard, M., Hocking, J., Spelman, T. & Aitken, C. Surveillance of drug use among young people attending a music festival in Australia. 2005-08. Drug and Alcohol Review (2009).
    • Lim, M., Hocking, J., Aitken, C. & Hellard, M. A randomised controlled trial of the impact of text and email messaging on the sexual health of young people BMJ (2009).
    • Matthews, G. V. et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin. Infect. Dis. 48, 650-658 (2009).
    • McBryde, E. et al. Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May - 3 June 2009. Euro Surveill 14 (2009).
    • Miller, E. R., Hellard, M. E., Bowden, S., Bharadwaj, M. & Aitken, C. K. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. J. Infect. 58, 375-382, (2009).
    • Moore, D. et al. Extending drug ethno-epidemiology using agent-based modelling. Addiction 104, 1991-1997 (2009).
    • Murray, R. J. et al. The Australasian Society for Infectious Diseases guidelines for the diagnosis, management and prevention of infections in recently arrived refugees: an abridged outline. Med. J. Aust. 190, 421-425 (2009).
    • Ngo, D., Schmidt, L., Higgs, P. & Fischer, A. Qualitative evaluation of a peer-based needle and syringe program in Vietnam International Journal of Drug Policy 20, 179-182 (2009).
    • Nguyen, O. K., Higgs, P. G. & Hellard, M. E. Limits to relying on expert information: the Delphi technique in a study of ethnic Vietnamese injection drug users in Melbourne, Australia. Social work in public health 24, 371-379, (2009).
    • Niemann, S. et al. Genomic diversity among drug sensitive and multidrup resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PloS one (2009).
    • Pedrana, A. et al. High Incidence of hepatitis C virus resolution and reinfection in a cohort of injecting drug users. Drug & Alcohol Review 28, A50 (2009).
    • Reid, G. & Aitken, C. Advocacy for harm reduction in China: a new era dawns. International Journal of Drug Policy (2009).
    • Stanisic, D. I. et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect. Immun. 77, 1165-1174, (2009).
    • Stoove, M. A., Dietze, P. M. & Jolley, D. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data. Drug Alcohol Rev 28, 347-352 (2009).
    • Sweeney, R., Conroy, A., Dwyer, R. & Aitken, C. The economic burden to the public health system of treating injecting related injury and disease in Australia (a cost of illness analysis). Aust. N. Z. J. Public Health (2009).
    • Wang, Y. H., Guy, R. & Hellard, M. The Victorian hepatitis C education program for GPs--an evaluation. Aust. Fam. Physician 38, 749-752 (2009).
    • Wang, Y. H., Guy, R. & Hellard, M. The Victorian hepatitis C education program for GPs--an evaluation. Aust. Fam. Physician 38, 749-752 (2009).
    • Woolley, I. J., Hutchinson, P., Reeder, J. C., Kazura, J. W. & Cortes, A. Southeast Asian ovalocytosis is associated with increased expression of Duffy antigen receptor for chemokines (DARC). Immunohematology / American Red Cross 25, 63-66 (2009).

 2008

  • Aitken C, Fry T, Grahlmann L, Masters T. Health perceptions of home-grown tobacco (chop-chop) smokers. Nicotine and Tobacco Research 2008; 10(3):413-416
  • Aitken C, Higgs P, Hellard M. (2008)  Buprenorphine injection in Melbourne, Australia – an update. Drug and Alcohol Review, 27(2):197-199
  • Aitken C, Lewis J, Tracy S, Bowden S, Bharadwaj M, Drummer H, Spelman T, Hellard M. (2008) High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 48(6): 1746-1752
  • Aitken C, Power R, Dwyer R. (2008) A very low response rate in an on-line survey of medical practitioners. Australian and New Zealand Journal of Public Health 32(3):288-289
  • Aitken C, Wain D, Lubman D, Hides L & Hellard M. (2008) Mental health screening among IDUs outside treatment settings – implications for research and health services. Mental Health and Substance Use: Dual Diagnosis 1(2):99-103
  • Aitken C, Higgs P, Hellard M. (2008) Buprenorphine injection in Melbourne, Australia – an update. Drug and Alcohol Review 27(2):197-199.
  • Aitken C, Tracy S, Revill P, Bharadwaj M, Bowden S, Winter R, Hellard M. (2008) Consecutive infections with different hepatitis C virus genotypes in an injecting drug user. Journal of Clinical Virology 41(4):293-296
  • Aitken C, Higgs P, Bowden S. (2008) Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission. Epidemiology & Infection 136:410-6
  • Chan K-Y, Stoové MA, Sringernyuang L, Reidpath DD. (2008) Stigmatization of AIDS patients: Disentangling Thai nursing students’ attitudes towards HIV/AIDS, drug use, and commercial sex. AIDS & Behavior 12:146-157
  • Chan K-Y, Stoové MA, Reidpath DD. (2008) Stigma, social reciprocity and exclusion of HIV/AIDS patients with illicit drug histories: A study of Thai nurses’ attitudes. Harm Reduction Journal 5:28
  • Cox H, McDermid C. (2008) Commentary: XDR Tuberculosis can be cured with aggressive treatment. Lancet 372:1363-5
  • Cox HS, Morrow M, Deutschmann P. (2008) The long term efficacy of DOTS short-course regimens for tuberculosis: a systematic review of disease recurrence after successful treatment. British Medical Journal 336:484-487
  • Genton B, D’Acremont V, Rare L, Bae K, Reeder JC, Alpers MP, Müller I. (2008) Plasmodium vivax and mixed infections are associated with severe malaria: A prospective cohort study from Papua New Guinea. PLoS Medicine 5:e127
  • Goller JL, Stoové MA, Hellard M. (2008) Commentary for 'Chlamydia testing and notification in Australia: more money, more tests.' Sex Transm Infect 84(7):569
  • Goller J, Gold J, Lim M, Spelman T, Guy R on behalf of the Victorian Primary Care Network for Sentinel Surveillance on BBVs and STIs (2008) HIV, syphilis and chlamydia in men who sex with men in Victoria: testing, risk behaviour and prevalence. Victorian Infectious Diseases Bulletin 11(1):5-9
  • Guy R, Gold J, Kaldor J (2008) Calibration, Performance Characteristics and Validation of HIV Incidence Assays: A Literature Review. Report commissioned by the World Health Organization
  • Guy R, Ayton D, Lim M, Higgins N, Pedrana A, Gibson K, Lewis J, Spelman T, White B, Kaldor J, Hellard M. (2008) Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications. Communicable Disease Intelligence 32(2):250-6
  • Higgs P, Owada K, Hellard M, Power R, Maher L. (2008) Gender, culture and harm: An exploratory study of female heroin users of Vietnamese ethnicity. Culture, Health and Sexuality 10(7):681-695
  • Higgs P, Kelsall J, Nguyen QC. (2008) Transitions to injecting and risk of hepatitis C transmission among ethnic Vietnamese heroin smokers in Melbourne, Australia. Hepatitis Monthly 8(2):115-120
  • Hodel EM, Marfurt J, Müller D, Rippert A, BorrmannS, Müller I, Reeder JC, Siba P, Beck H-P (2008) Lack of multiple copies of pfmdr1 genes in Papua New Guinea. Trans Roy Soc Trop Med Hyg 102:1151-1153
  • Lemoh C, Biggs B, Hellard, M. (2008) Working with West African migrant communities on HIV prevention in Australia. Sexual Health 5: 313-4
  • Lim MSC, Hellard ME, Hocking JS, Aitken CK. (2008) A cross-sectional survey of young people attending a music festival: associations between drug use and musical preference. Drug and Alcohol Review 27(4):439-41
  • Lim MSC, Hocking JS, Hellard ME, Aitken CK (2008) SMS STI: A review of the uses of mobile phone text messaging in sexual health. International Journal of STD and AIDS 19: 287–90
  • Marfurt J, Müller I, Sie A, Oa O, Reeder JC, Smith TA, Beck H-P, Genton B. (2008) The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine or chloroquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea. Malaria Journal 7:61
  • Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck H-P, Picot S, Genton B. (2008) Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulphadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1. J Inf Dis 198:409-417
  • Meintjes G, Lawn S, Scano F, Maartens G, French M, Worodria W, Elliott JH, et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8:516-523
  • Norman J, Walsh N, Mugavin J, Stoove MA, Kelsall J, Austin K, Lintzeris N. (2008) A peer and community-based model of HCV treatment delivery to injecting drug users: an evaluation of patient perspectives. Harm Reduction Journal 5:8
  • Pankonin, C., Higgs, P., Reid, G., & Aitken, C. 2008. Selling Syringes to IDUs:  A Study of Five Pharmacies in Hanoi, Vietnam, Journal of Infection in Developing Countries, 2 (1):51-58.
  • Pedrana A, Aitken C, Higgs P, Hellard M. (2008) Blood borne viruses and risk behaviours among transient farm workers in rural Victoria. Australian Journal of Rural Health 16(3):143-149
  • Stoové MA, Fry CL, Lintzeris N. (2008) Approximating predictive risk for community-based HCV surveillance, education and prevention: Application of a new weighted scoring system to the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Harm Reduction Journal 5:12
  • Stoové M, Dietze P, Aitken C, Jolley D. (2008) Mortality among injecting drug users in Melbourne: a 16-year follow-up of the VICS cohort. Drug and Alcohol Dependence 96:281-285
  • Thammanichanond D, Yotnda P, Aitken C, Earnest-Silveira L, Jackson D, Hellard M, McCluskey J, Torresi J, Bharadwaj M, Modified recombinant adenoviral constructs encoding Hepatitis C Virus proteins are potent inducers of HCV-specific T Cell Responses. Clinical Immunology 128 (3):329-3339
  • Walsh, N., Gibbie, T., & Higgs, P. (2008). The development of peer educator-based harm reduction in northern Vietnam, Drug and Alcohol Review, 27(2): 209-212.
  • Walsh N, Lim MSC, Hellard ME. (2008) Using a surveillance system to identify and treat newly acquired hepatitis C infection. Journal of Gastroenterology and Hepatology 23(12):1891-4
  • Winter R, Nguyen O, Higgs P, Armstrong S, Duong D, Thach M, Aitken C, Hellard M. (2008) Integrating enhanced hepatitis C testing and counselling in research. International Journal of Drug Policy 19(1):66-70
  • Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vontanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Hui Lun W, Kamarulzaman A, Tau G, Ty Ali A, Kishore K, Bain M, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S. (2008) Neurological disorders are prevalent in HIV positive outpatients in the Asia- Pacific Region. Neurology 71:50-6

 

2007

 

  • Aitken C, Bharadwaj M, Bowden DS, Hellard ME, Molecular epidemiology of the hepatitis C virus in a social network of injecting drug users: an update. Sociedad Iberoamericana de Información Científica (Salud): Expertos Invitados, 3rd May 2007 (http://www.siicsalud.com/dato/dat052/07427002.htm)
  • Aitken CK, Higgs P, Bowden S, Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission. Epidemiology & Infection 2007; 17:1-7
  • Ayton DR, Guy RJ, Woolley IJ, Hellard ME. (2007) Cambodian-born individuals diagnosed with HIV in Victoria: epidemiological findings and health service implications. Sexual Health 4(3):209
  • Caulkins JP, Dietze P, Ritter A. (2007) Dynamic compartmental model of trends in Australian drug use. Health Care Manag Sci 10(2):151-62
  • Giles, M.L., S.M. Garland, S.R. Lewin, and M.E. Hellard, What are the barriers to offering HIV testing in an antenatal setting? A national study of obstetricians. AIDS, 2007. 21(12): p. 1601-6.
  • Gold J, Hocking J, Hellard M. (2007) The feasibility of recruiting young men in rural areas from community football clubs for STI screening. Australian and New Zealand Journal of Public Health 31(3):243-146
  • Goller JL, Jolley D, Ringwald P, Biggs BA. (2007) Regional differences in the response of Plasmodium vivax malaria to Primaquine as anti-relapse therapy Am J Trop Med Hyg 76(2): 203-207
  • Goller J, Gold J, Lim M, Guy R. (2007) Victorian Primary Care Network for Sentinel Surveillance on BBVs and STIs: an update. Victorian Infectious Diseases Bulletin 10(2):37-38
  • Guy RJ, McDonald AM, Bartlett MJ, Murray JC, Giele CM, Davey TM, Appuhamy RD, Knibbs P, Coleman D, Hellard ME, Grulich AE, Kaldor JM. (2007)  HIV diagnoses in Australia: diverging epidemics within a low-prevalence country. Med J Aust 187(8): 437-440
  • Guy R, Lim M, Wang Y, Medland N, Anderson A, Roth N, Hellard M. (2007) A new surveillance system for monitoring HIV infection in Victoria, Australia. Sexual Health 4:195-9
  • Hellard M, Hocking J, Aitken CK. (2007) Tattooing in prisons - not such a pretty picture. American Journal of Infection Control 35(7): 477-480
  • Hides L, Lubman D, Devlin H, Cotton S, Aitken, C, Gibbie T, and Hellard M. (2007) Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Australian and New Zealand Journal of Psychiatry 41(2): 166-168.
  • Horyniak D, Armstrong S, Higgs P, Wain D, Aitken C. (2007) “Poor Man’s Smack”: A qualitative study of buprenorphine injecting in Melbourne, Australia. Contemporary Drug Problems 34(3):525-548
  • Lim M, Hellard M, Aitken C, Hocking J. (2007) Sexual risk behaviour, self-perceived risk and knowledge of sexually transmissible infections among young Australians attending a music festival. Sexual Health 4(1):51-56
  • Lim MSC, Sundaram K, Aitken CK, Hellard ME, Blood-borne Viruses and Risk Behaviours among Injecting Drug Users attending Needle and Syringe Programs in Victoria’s Eastern Metropolitan Region. Australian Journal of Primary Health 2007; 13 (3):69-76
  • Nielsen S, Dietze P, Dunlop A, Muhleisen, P, Lee N, Taylor D. (2007) Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified. Drug Alcohol Rev 26(2):143-51
  • Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D. (2007) Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction 102(4):616-22
  • Nguyen O, Dore G, Kaldor J, Hellard M. (2007) Recruitment and follow-up of injecting drug users in the setting of early HCV treatment: insights from the ATAHC study. International Journal of Drug Policy 18(5): 447-51
  • Read TR, Hocking J, Sinnott V, Hellard M. (2007) Risk factors for incident HIV infection in men having sex with men: a case-control study. Sexual Health 4(1):35-9
  • Wade AJ, Hocking J, Hellard M. (2007) Chlamydia Prevalence in Heterosexual Men in Melbourne; a Community-based Study [letter] Sexual Health 4(2):137-8
  • Walsh N, Higgs P, Crofts N. Recognition of HCV co-infection in HIV positive injecting drug users in Asia. JAIDS 45(3):363-4

 

2006

  • Dietze P, Jolley D, Fry C, Bammer G, Moore D. (2006) When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug & Alcohol Dependence 84: 223-230
  • Giles ML, Garland SM, Grover SR, Lewin S, Hellard ME.(2006) The impact of an educational campaign on the management of pregnant women with a blood borne viral infection. MJA 184:389-392
  • Giles M, Hellard M, Lewin S, Mijch A. (2006) The evidence for a change in antenatal HIV screening policy in Australia. MJA 185(4):217-220
  • Giles M, Harwood H-M, Gosling DA, Hennessy D, Pearce CT, Daley AJ. (2006) What is the best screening method to detect Serratia marcescens colonization during an outbreak in a neonatal intensive care nursery? Journal of Hospital Infection 62(3):349-52
  • Giles M. and Garland, S. (2006) A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines.  Australian and New Zealand Journal of Obstetrics and Gynaecology 46(4):311-315
  • Giles M. and Garland S. (2006) Human papillomavirus infection: An old disease, a new vaccine. Aust N Z J Obstet Gynaecol, 46(3):180-5
  • Hellard M, Nguyen O, Guy R, Jardine D, Mijch A, Higgs P. (2006) The prevalence and risk behaviours associated with the transmission of blood borne viruses among ethnic-Vietnamese injecting drug users. Aust N Z J Public Health 30(6): 519-25.
  • Higgs P, Moore D, Aitken CK. (2006) Engagement, reciprocity and advocacy: Ethical harm reduction practice in research with injecting drug users. Drug and Alcohol Review 25(5):419-23
  • Higgs P. (2006) Was this the result you were expecting? Sexual Health 3(1):59-60
  • Hocking J, Lim M, Fairley CK, Vidanpathirana J, Hellard M.(2006) Chlamydia testing in general practice - a survey of Victorian general practitioners. Sexual Health 3(4):241-244
  • Hocking JS, Willis J, Tabrizi S, Fairley CK, Garland SM, Hellard M. (2006) A chlamydia prevalence survey of young women living in Melbourne. Sexual Health 3(4):235-240
  • Hocking JS, Lim M, Read T, Hellard M.(2006) Postal surveys of physicians gave superior response rates over telephone interviews in a randomised trial. Journal of Clinical Epidemiology 59(5):521-524
  • Hocking JS, Fairley CK. (2006) Associations between condom use and rectal and urethral chlamydia in men. Sexually Transmitted Diseases 3(4):256-8
  • Jaworowski A, Ellery P, Maslin C, Naim E, Heinlein CA, Paukovics G, Hocking JS, Sonza S, Crowe S. (2006) Normal CD16 Expression and Phagocytosis of Mycobacterium avium Complex by Monocytes from a Current Cohort of HIV-1 Infected Patients. Journal of Infectious Diseases 193(5):693-7
  • Lim M, Guy R, Hellard M. (2006) A profile of HIV testing in Victoria, 1984 to 2004. Commun Dis Intell 30:366-371 

2005

 

  • Bowden S, McCaw R, White P, Crofts N, Aitken CK. (2005) Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. Journal of Viral Hepatitis 12:322–324
  • Fairley CK, Hocking JS, Chen M, Gunn J. (2005) No barriers to chlamydia testing in sexually active young women [letter] Med J Aust 183(10):548-549
  • Fairley K, Hocking J, Medland N. (2005) Syphilis: back on the rise, but not unstoppable. Med J Aust 183(4):172-173
  • Giles M, Mijch A, Garland S. (2005) Assisted Reproduction for HIV Infected Couples. Sexual Health 2(4):223-7
  • Giles ML, Mijch A. (2005) Breast milk pasteurization in developed countries to reduce HIV transmission. Do the benefits outweigh the risks? Infectious Diseases in Obstetrics and Gynecology 13(4):237-240
  • Greengrass VL, Turnbull SP, Hocking J, Dunne A, Tachedjian G, Corrigan GE, Crowe SM. (2005) Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. Current HIV Research 3(2):183-190
  • Guy RJ, Lambert SB, Kelly HA. (2005) Estimating influenza vaccine effectiveness in an outbreak when anti-viral medications were used as a control measure. Aust N Z J Public Health 29(6):540-3
  • Guy RJ, Leslie DE, Simpson K, Hatch B, Leydon J, Hellard ME, Kelly HA. (2005) Sustained increase in infectious syphilis notifications in Victoria (letter) Med J Aust 183(4):218
  • Guy RJ, Breschkin AM, Keenan CM, Catton MG, Enriquez AM, Hellard ME. (2005) Improving HIV Surveillance in Victoria: The Role of the "Detuned" Enzyme Immunoassay. JAIDS 38(4):495-499
  • Hercus M, Lubman D, Hellard M. (2005) Blood-borne viral and sexually transmissible infections among psychiatric populations: what are we doing about them? Australian and New Zealand Journal of Psychiatry 39(10):849-855.
  • Higgs P, and Kelsall J. (2005) Doing peer-based research with ethnic Vietnamese heroin users. New Community Quarterly 3(1):24-6
  • Hocking J, Fairley CK. (2005) Do the characteristics of sexual health centre clients predict chlamydia infection sufficiently strongly to allow selective screening? Sexual Health 2(3):185-192
  • Hocking JS, Fairley CK.(2005) High chlamydia incidence among clients attending a large urban STI clinic. Australian and New Zealand Journal of Public Health 29(4):389
  • Jordens J, and Higgs P. (2005) Couches vs Karaoke: Ethnic Vietnamese user views on safe injecting facilities in Melbourne Australia. New Community Quarterly 3(1):19-23
  • Lee DM, Binger A, Hocking J, Fairley CK. (2005) The incidence of sexually transmissible infections among frequently screened sex workers in a decriminalised and regulated system in Melbourne. Sexually Transmissible Infections 81(5):434-6
  • Lim M, Hellard M, Aitken CK. (2005) Where have all the bloody teaspoons gone? A longitudinal cohort study of the displacement of teaspoons in an Australian research institute. British Medical Journal 331:1498-1500

 

2004

 

  • Aitken CK, Bowden S, Hellard M, Crofts N. (2004) Indications of immune protection from hepatitis C infection. Journal of Urban Health 81(1):58-60
  • Aitken CK, Bowden S, McCaw R, Jardine D, Hellard M, Higgs P, Nguyen O, Crofts N. (2004) Change in hepatitis C virus genotype in injecting drug users. Journal of Medical Virology 74:543-545
  • Aitken CK, McCaw R, Bowden S, Tracy SL, Kelsall J, Higgs P, Kerger M, Nguyen H, Crofts N. (2004) Molecular epidemiology of the hepatitis C virus in a social network of injecting drug users. Journal of Infectious Diseases 190(9):1586-1595
  • Dowd H, and Higgs P. (2004) Psychiatric comorbidity in general practice. Australian Family Physician 33(6):386
  • Giles ML, Mijch AM, Garland SM, Grover SR, Hellard ME. (2004) HIV and Pregnancy In Australia. Obstetrics and Gynaecology 44:192-199
  • Giles ML, Sasadeusz J, Garland SM, Grover SR, Hellard ME. (2004) An audit of obstetricians’ management of women potentially infected with blood borne viruses. MJA 180(7):328-332
  • Guy R, and Hellard M. (2004) Rising HIV infections in Victoria; the need for a new approach to preventative interventions. Sexual Health 1(1):69-71
  • Guy RJ, Andrews RM, Kelly HA, Leydon JA, Riddell MR, Lambert SB, Catton MG. (2004) Mumps and rubella: a year of enhanced surveillance and laboratory testing. Epidemiol Infect 132(3):391-8
  • Guy RJ, Di Natale R, Kelly HA, Lambert SB, Tobin S, Robinson PM, Tallis G, Hampson AW. (2004) Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy. Med J Aust 180(12):640-2
  • Hellard ME, Hocking JS, Crofts N. (2004) The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiology and Infection132(2):409-15
  • Hellard M, and Aitken C. (2004) HIV in prison: what are the risks and what can be done? Sexual Health 1(1):107-113
  • Hocking J, Keenan C, Catton M, Breschkin A, Guy R, Hellard M. (2004) Rising HIV infection in Victoria: an analysis of surveillance data. Aust NZ J Public Health 28(3):217
  • Kedzierska K, Paukovics G, Handley A, Hewish M, Hocking J, Cameron PU, Crowe SM. (2004) Interferon-gamma therapy activates human monocytes for enhanced phagocytosis of Mycobacterium avium complex in HIV-infected individuals. HIV Clinical Trials 5(2):80-5
  • Kemp R and Aitken CK. (2004) The development of New Zealand’s Needle and Syringe Exchange Programme. International Journal of Drug Policy 15(3):202-206
  • Marshall JA, Hellard ME, Sinclair MI, Fairley CK, Cox BJ, Catton G, Kelly H, Wright PJ. (2004) Failure to detect norovirus in a large group of asymptomatic individuals. Public Health 118:230-233
  • Mitakakis TZ, Fairley CK, Sinclair M, Leder K, Hellard ME. (2004) Food safety in the homes of Melbourne families J Food Prot 67(4):818-22
  • Mitakakis TZ, Wolfe R, Sinclair MI, Fairley CK, Leder K, Hellard M.(2004) Dietary intake and domestic food preparation and handling as risk factors for gastroenteritis – a case control study. Epidemiol Infect 132(4):601-6
  • Mitchell H, Hocking J, Saville M. (2004) Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case control study. Acta Cytologica 48(5):595-600
  • Robins-Browne RM, Bordun A-M, Tauschek M, Bennett-Wood V, Russell J, Oppedisano F, Lister NA, Bettelheim KA, Fairley CK, Sinclair MI, Hellard ME. (2004) Atypical enteropathogenic Escherichia coli as a cause of community-acquired gastroenteritis in Melbourne, Australia. Emerg Infect Dis 10(10):1797-805

 

2003

  • Counahan M, Hocking J, Fairley CK. (2003) Enhanced chlamydia surveillance indicates more screening needed. Med J Aust 178(10):523
  • Dite GS, Jenkins M, Southey M, Hocking J, Giles GG, et al. (2003) Strong familial risks associated with early-onset breast cancer are only partly BRCA1- or BRCA2-related. Journal of the National Cancer Institute 95(6):448-57
  • Giles M, Sasaduesz J, Hellard M, Hepatitis C and pregnancy: an update. Aust NZ J Obstetrics and Gynae 43:290-293
  • Hellard ME, Sinclair MI, Forbes AB, Kirk M, Fairley CK. (2003) The cost of community gastroenteritis. Journal of Gastro & Hepatology 18:322-328
  • Hellard M, Aitken C, Mackintosh A, Ridge A, Bowden S. (2003) An investigation of hepatitis C and commercial body piercing. American Journal of Infection Control 31(4):15-220
  • Hellard M, Aitken C, Mackintosh A, Ridge A, Bowden S, Crofts N. (2003) A report on infection control practices and knowledge of hepatitis C virus among body piercing practitioners in Victoria. Environmental Health 4:39-54
  • Hellard M, Hocking J, Willis J, Dore G, Fairley C. (2003) Risk Factors Leading To Cryptosporidium Infection In Men Who Have Sex With Men. Sex Transm Infect 79:412-414
  • Hocking J, Fairley CK, Counahan M, Crofts N. (2003) The pattern of notification and testing for genital Chlamydia trachomatis infection in Victoria, 1998-2000: an ecological analysis. Australian and New Zealand Journal of Public Health 27(4):405-8
  • Hocking J, Tabrizi S, Jolley D, Garland S, Fairley CK. (2003) A pilot study to estimate the rate of response to a request to provide a mailed self-collected urine specimen for chlamydia testing - recruitment via mail versus recruitment via mail and telephone contact. Sexually Transmitted Infections 79:346-347
  • Hocking J, and Fairley CK. (2003) Need for genital Chlamydia trachomatis screening in Australia. Australian and New Zealand Journal of Public Health 27:80-1
  • Leder K, Sinclair M, Mitakakis T, Hellard M, Forbes A, Fairley C. (2003) A community-based study of respiratory episodes in Melbourne, Australia. Australian and New Zealand Journal of Public Health 27(4):399-404
  • Marshall JA, Hellard ME, Sinclair MI, Fairley CK, Cox BJ, Catton MG, Kelly H and Wright PJ. (2003) The incidence and characteristics of endemic Norwalk-like virus-associated gastroenteritis. Journal of Medical Virology 69(4):568-578
  • Mitchell H, and Hocking J. (2003) Improvements in the protection against adenocarcinoma of the cervix from participation in cervical screening. Cancer (Cancer Cytopathology) 99:336-341


2002

  • Aitken CK, Moore D, Higgs P, Kelsall J, Kerger M. (2002) The impact of a police crackdown on a street drug scene: evidence from the street. International Journal of Drug Policy 13(3):189-198
  • Aitken CK and Delalande C. (2002) A Public Health initiative for steroid users in Victoria. Australian Journal of Primary Health 8(2):21-23
  • Aitken CK, Kerger M, Crofts N. (2002) Peer-delivered hepatitis C testing and counselling - a means of improving the health of injecting drug users. Drug and Alcohol Review 21(1):33-38
  • Aitken CK, and Higgs P. (2002) Severe vein damage caused by Temezepam injecting. Australian and New Zealand Journal of Public Health 26(1):79
  • Aitken CK, Delalande C, Stanton K. (2002) Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic steroid injectors in Victoria, Australia. Drug and Alcohol Dependence 65(3):303-308
  • Beyer L, Crofts N, Reid G. (2002) Drug offending and criminal justice responses: practitioners' perspectives. International Journal of Drug Policy 13(3):199-207
  • Hocking J, Higgs P, Keenan C, Crofts N. (2002) HIV among injecting drug users of Indo-Chinese ethnicity in Victoria [letter]. MJA 176(4):191-2
  • Mitchell H, and Hocking J. (2002)  Influences on the risk of recurrent high grade cervical abnormality. International Journal of Gynaecological Cancer 12:728-734
  • Reid G, Higgs P, Beyer, L Crofts N. (2002) Vulnerability among Vietnamese drug users in Australia: challenges for change. International Journal of Drug Policy 13(2):127-136

 

2001

  • Beyer L, Reid G, Crofts N. (2001) Ethnic based differences in drug offending. Australian and New Zealand Journal of Criminology 34(2):169-181
  • Crofts N. (2001) Going where the epidemic is: Control of Hepatitis C among injecting drug users. Australian Family Physician 30(5):420-425
  • Crofts N. (2001) Prises de risques lors de la premiere injection intraveineuse de drogue [letter]. Annales de Medecine Intern 151(B):B5-B8
  • Fry C, Dietze P, Crofts N. (2001) Naloxone distribution: remembering hepatitis C transmission as an issue [letter]. Addiction 95(12):1865-1866
  • Higgs P, Maher L, Jordens J, Dunlop A, Sargent, P. (2001) Harm Reduction and drug users of Vietnamese ethnicity. Drug and Alcohol Review 20(2):239-245
  • Hocking J, Rodger A, Rhodes D, Crofts N. (2001) HIV seroconverters: Using surveillance to characterize people with incident HIV infection in Victoria, Australia. European Journal of Epidemiology 17(2):157-161
  • Kedzierska K, Mak J, Jaworowski A, Greenway A, Violo A, Chan HT, Hocking J, Purcell D, Sullivan JS, Mills J, Crowe S. (2001) Nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS 15(8):945-955
  • Maher L, Sargent P, Higgs P, Crofts N, Kelsall J, Le TT. (2001) Risk Behaviours of Young Indo-Chinese Injecting Drug Users in Sydney and Melbourne Australian and New Zealand Journal of Public Health 25(1):50-54
  • Mitchell H, and Hocking J. (2001) Predictors of early rescreening in the National Cervical Screening Program, Australia. Australian and New Zealand Journal of Public Health 25(4):334-338
  • Reid G, Aitken C, Beyer L, Crofts N. (2001) Ethnic communities' vulnerability to involvement with illicit drugs. Drugs: Education, Prevention & Policy 8(4):359-374
  • Reid G, Beyer L, Aitken CK, Crofts N. (2001) Markers of ethnicity and their effect on measuring illicit drug use by ethnic groups. Drug and Alcohol Review 20(3):309-317
  • Reid G, Crofts N, Beyer L. (2001) Drug Treatment Services for Ethnic Communities in Victoria, Australia: an examination of cultural and institutional barriers. Ethnicity & Health 6(1):13-26
  • Rodger A, Lanigan A, Hocking J, Crofts N. (2001) Tracing and recruiting a cohort with community acquired hepatitis 25 years later. Australian and New Zealand Journal of Public Health 25(6):489-493
  • Sargent P, Maher L, Higgs P, Crofts N. (2001)  Di chich lan dau tien (injecting the first time): Initiation to injecting drug use among Indo-Chinese young people. Health Promotion Journal of Australia 12(3):242-247

 

2000

  • Aitken CK, Kerger M, Crofts N. (2000) Drivers who use illicit drugs: behaviour and perceived risks. Drugs: Education, Prevention and Policy 7(1):39-50
  • Crofts N, Caruana S, Bowden S, Kerger M. (2000) Minimising harm from hepatitis C virus needs better strategies. BMJ 321(7265):899
  • Eicher AD, Crofts N, Benjamin S, Deutschmann P, Rodger AJ. (2000) A certain fate: spread of HIV among young injecting drug users in Manipur, North-East India. AIDS Care 12:4:497-504
  • Hocking J, Rodger A, Rhodes D, Crofts N. (2000) Late presentation of HIV infections associated with prolonged survival following AIDS diagnosis. International Journal of STDs and AIDS 11:503-508
  • Ogilvie E, Veit F, Crofts N, Thompson SC. (2000) Hepatitis infection among adolescents resident in the Melbourne Juvenile Justice Centre: Risk factors and challenges Youth Studies Australia 19(3):25-30
  • Reid G, Crofts N. (2000) Rapid assessment of drug use and HIV vulnerability in South East and East Asia. International Journal of Drug Policy 11:113-124
  • Roberts C, Crofts N. (2000) Hitting up in the Top End: characteristics of needle exchange clients in Darwin. Australian and New Zealand Journal of Public Health 24(1):82-85
  • Rodger AJ, Roberts S, Lanigan A, Bowden S, Crofts N. (2000) Assessment of Long Term Outcomes of Community-Acquired Hepatitis C Infection in a Cohort with Sera Stored From 1971 - 1975. Hepatology 32:582-7

1999

  • Aitken CK and Delalande C. (1999). Are people who inject steroids risking blood-borne virus infection? Infectious Diseases Bulletin 2(3):54
  • Aitken CK, Brough R and Crofts N. (1999) Injecting drug use and blood-borne viruses: a comparison of rural and urban Victoria, 1990-1995. Drug and Alcohol Review 18(1):47-52
  • Carlin JB, and Hocking J. (1999) Design of Cross-sectional Surveys using Cluster Sampling: an Overview with Australian Case-studies. Australian and New Zealand Journal of Public Health 23(5):546-551
  • Crofts N. (1999) Old virus, modern ways: the challenge for control of hepatitis C. Today's Life Science Nov/Dec 1999:40-42
  • Crofts N. (1999) Bali high? Intravenous drug use in Indonesia - when will we ever learn? [Editorial] International Joural of Drug Policy 10(2):79-81
  • Crofts N, Aitken CK, Kaldor J. (1999) Reply to comment on "The force of numbers: ..." [MJA 170(5), p.220-1], M JA 171(3):165
  • Crofts N, Aitken CK, Kaldor J. (1999) The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. MJA 170(5):220-1
  • Crofts NJ, and Deany PR. (1999) A global voice for harm reduction: the establishment of regional harm reduction networks. Harm Reduction Digest 5, Drug and Alcohol Review 18:221-229
  • Kermode M, Crofts N, Speed B, Miller P, Streeton J. (1999) Tuberculosis infection and homelessness in Melbourne, Australia, 1995-1996. Int J Tuberc Lung Dis 3(10):901-7
  • Mather D, Crofts N. (1999) A computer model of the spread of hepatitis C virus among injecting drug users. Eur J Epidemiol 15(1):5-10
  • Rhodes T, Stimson GV, Crofts N, et al. (1999) Drug injecting, rapid HIV spread, and the risk environment: implications for assessment and response. AIDS 13 (suppl A):S259-69
  • Rodger A, Hocking J, McEachern A. (1999) Chlamyida trachomatis in Victoria. Victorian Infectious Diseases Bulletin 2(1) 3-5
  • Rodger A, Hocking J, Warren R, Snow J, Aboagye-Kwarteng T, Crofts N. (1999) Prevalence of genital Chlamydia trachomatis in male clients of female sex workers in Melbourne. Venerology 12(4):129-132
  • Rodger AJ, Thomson JA, Thompson SC, Jolley D, Mijch AM, Lanigan A, Crofts N. (1999) Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: results of a pilot study. J Gastroenterol Hepatol 14(3):269-73
  • Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. (1999) The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 30(5):1299-301
  • Stevenson E, Crofts N, Thompson SC. (1999) Making too much of too little: Interpreting HIV surveillance data. Venereology 11(3):30-33
  • Thompson SC and Norris M. (1999) Hepatitis B vaccination of personnel employed in Victorian hospitals: are those at risk adequately protected? Infect Control Hosp Epidemiol 20(1):51-4
  • Watson R, Crofts N, Mitchell C, Aitken C, Hocking J, Thompson S. (1999) Risk factors for hepatitis C transmission in the Victorian population: a telephone survey. Australian and New Zealand Journal of Public Health 23(6):622-626

 

1998

  • Banatvala N, Rodger A, Denney A, Howarth J,. Morbidity and mortality among Rwandan refugees repatriated from Zaire - November 1996. Prehospital and Disaster Medicine. 1998;58:124-7
  • Brown, K., and Crofts N. Health care costs of a continuing epidemic of hepatitis C virus among injecting drug users. ANZ J Public Health 1998, 22;3:384-388
  • Crofts N, Costigan G, Narayanan, P, Gray J, Dorabjee J, Langkam B, Singh M, Peak A, Aquino C, Deany P, for the Asian Harm Reduction Network, (1998). Harm Reduction in Asia: a successful response to hidden epidemics. AIDS, 12(SB):S109-S115.
  • Crofts N, Reid, G, Deany P, in collaboration with the Asian Harm Reduction Network, (1998). Injecting drug use and HIV Infection in Asia. AIDS, 12(SB):S69-S78.
  • Crofts NJ, Reid G and Deany PR, Injecting drug use and HIV Vulnerability in South East Asia. AIDS 1998, Vol 12 Suppl B.
  • Delalande, C, Aitken, CK, Mercuri P, Stanton K, (1998). Risky practices among people who inject steroids. Medical Journal of Australia, 169(1), p.62.
  • Kermode M, Crofts N, Miller P, Speed B, and Streeton J. Health indicators and risks among people experiencing homelessness in Melbourne, 1995-96. ANZ J Public Health 1998, 22;4:464-470
  • Linger H, Burstein, F, Zaslavsky, A, Aitken, C, Crofts N, (1998). Conceptual development of an information systems framework for improving continuity in epidemiological research. European Journal of Epidemiology, 14, pp.587-93.
  • Louie R, Krouskos, D, Gonzalez, M, and Crofts N, Vietnamese-speaking injecting drug users in Melbourne: the need for harm reduction. ANZ J Public Health 1998, 22;4:481-484
  • MacDonald M, Wodak A, Ali R, Crofts N, Cunningham PH, Dolan K, Kelaher M, Loxley WM, van Beek I, Kaldor JM HIV prevalence and risk behaviour in needle exchange attenders: a national study. Med J. Aust March 1997, 166:237-240
  • Reid G, Speed B, Miller P, Cooke F, Crofts N. (1998) A methodology for sampling and accessing homeless individuals in Melbourne, 1995-96. Aust N Z J Public Health 22(5):568-72
  • Rhodes D, Hocking J, Crofts N, Rodger A, Gonorrhoea Infection in VictoriaÄ..on the Rise? Victorian Infectious Diseases Bulletin 1998; 1(2):31-32.
  • Rodger AJ, Thomson J, Thomson S, Crofts N, Jolley D, Lanigan A, Mitjch A. Assessment of Long Term Outcomes of Hepatitis C Virus Infection In A Cohort Of Patients With Acute Hepatitis In 1971-1975 À Results of a Pilot Study. J Gastroenterology and Hepatology October 1998
  • Smith A, Jolley D, Hocking J, Benton K, Gerofi J, Factors affecting men's liking of condoms they have used. International Journal of STD and AIDS 1999;10:258-262.
  • Smith A, Jolley D, Hocking J, Benton K, Gerofi J,